Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP544819.RAPYbwnm2f5PGp-Na16ZCZ9-xntHZxwBT5iH8x1l2Qj18130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP544819.RAPYbwnm2f5PGp-Na16ZCZ9-xntHZxwBT5iH8x1l2Qj18130_assertion type Assertion NP544819.RAPYbwnm2f5PGp-Na16ZCZ9-xntHZxwBT5iH8x1l2Qj18130_head.
- NP544819.RAPYbwnm2f5PGp-Na16ZCZ9-xntHZxwBT5iH8x1l2Qj18130_assertion description "[Deletion of the NS1, but not NS2, protein resulted in three major effects: (i) an increased activation and proliferation of CD8+ T cells that express CD103, a tissue homing integrin that directs CD8+ T cells to mucosal epithelial cells of the respiratory tract and triggers cytolytic activity; (ii) an increased activation and proliferation of Th17 cells, which have recently been shown to have anti-viral effects and also indirectly attract neutrophils; and (iii) decreased activation of IL-4-producing CD4+ T cells--which are associated with enhanced RSV disease--and reduced proliferation of total CD4+ T cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP544819.RAPYbwnm2f5PGp-Na16ZCZ9-xntHZxwBT5iH8x1l2Qj18130_provenance.
- NP544819.RAPYbwnm2f5PGp-Na16ZCZ9-xntHZxwBT5iH8x1l2Qj18130_assertion evidence source_evidence_literature NP544819.RAPYbwnm2f5PGp-Na16ZCZ9-xntHZxwBT5iH8x1l2Qj18130_provenance.
- NP544819.RAPYbwnm2f5PGp-Na16ZCZ9-xntHZxwBT5iH8x1l2Qj18130_assertion SIO_000772 21533073 NP544819.RAPYbwnm2f5PGp-Na16ZCZ9-xntHZxwBT5iH8x1l2Qj18130_provenance.
- NP544819.RAPYbwnm2f5PGp-Na16ZCZ9-xntHZxwBT5iH8x1l2Qj18130_assertion wasDerivedFrom befree-20140225 NP544819.RAPYbwnm2f5PGp-Na16ZCZ9-xntHZxwBT5iH8x1l2Qj18130_provenance.
- NP544819.RAPYbwnm2f5PGp-Na16ZCZ9-xntHZxwBT5iH8x1l2Qj18130_assertion wasGeneratedBy ECO_0000203 NP544819.RAPYbwnm2f5PGp-Na16ZCZ9-xntHZxwBT5iH8x1l2Qj18130_provenance.